1. Home
  2. APPN vs SUPN Comparison

APPN vs SUPN Comparison

Compare APPN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$37.92

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$41.28

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPN
SUPN
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
APPN
SUPN
Price
$37.92
$41.28
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$29.80
$61.60
AVG Volume (30 Days)
846.3K
531.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
101.59
N/A
EPS
N/A
N/A
Revenue
$226,743,000.00
$392,755,000.00
Revenue This Year
$13.79
$22.70
Revenue Next Year
$10.56
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
28.29
N/A
52 Week Low
$18.63
$41.11
52 Week High
$46.06
$59.68

Technical Indicators

Market Signals
Indicator
APPN
SUPN
Relative Strength Index (RSI) 56.42 30.39
Support Level $35.88 N/A
Resistance Level $43.92 $52.33
Average True Range (ATR) 2.09 1.22
MACD -0.92 -0.32
Stochastic Oscillator 46.66 8.01

Price Performance

Historical Comparison
APPN
SUPN

About APPN Appian Corporation

Appian Corp is an enterprise software company whose platform unifies process orchestration, artificial intelligence, and data for automating complex business operations. Its platform combines low-code application development, process automation and process mining, AI agents, and a data fabric that connects information across an organization's existing systems without replicating it. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based, with the remainder coming from services, and much of that subscription revenue comes from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations and also has a presence internationally.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: